Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
ciletatug vedotin (RC118) / Rongchang Pharma
NCT05205850: A Study of RC118 in Patients With Locally Advanced Unresectable or Metastatic Malignant Solid Tumors	Recruiting	1/2	135	RoW	RC118-ADC, RC118 for injection	RemeGen Co., Ltd.	Advanced Solid Tumor	09/25	12/25
NCT06038396: A Study of RC118 Plus Toripalimab in Patients With Locally Advanced Unresectable or Metastatic Solid Tumors	Recruiting	1/2	64	RoW	RC118, RC118 for injection, Toripalimab, Toripalimab for injection, JS001	RemeGen Co., Ltd.	Advanced Solid Tumor	02/26	08/26
NCT04914117: A Study of RC118 in Patients With Locally Advanced Unresectable/Metastatic Solid Tumours	Completed	1	7	RoW	RC118 for injection	RemeGen Co., Ltd.	Unresectable Solid Tumor, Metastatic Solid Tumor, Locally Advanced Solid Tumor	11/22	03/23